Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years

IMPORTANCE: SARS-CoV-2 vaccines are authorized for use in most age groups. The safety of SARS-CoV-2 vaccines is unknown in children younger than 5 years. OBJECTIVE: To retrospectively evaluate the safety of the BNT162b2 vaccine used off-label in children younger than 5 years compared with the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Toepfner, Nicole, von Meißner, Wolfgang C. G., Strumann, Christoph, Drinka, Denisa, Stuppe, David, Jorczyk, Maximilian, Moor, Jeanne, Püschel, Johannes, Liss, Melanie, von Poblotzki, Emilie, Berner, Reinhard, Moor, Matthias B., Chao, Cho-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579908/
https://www.ncbi.nlm.nih.gov/pubmed/36255723
http://dx.doi.org/10.1001/jamanetworkopen.2022.37140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579908/
https://www.ncbi.nlm.nih.gov/pubmed/36255723
http://dx.doi.org/10.1001/jamanetworkopen.2022.37140

Ejemplares similares